May 2026 Deep Blue Medical Advances expanded its hernia repair portfolio through broader commercialization of the T-Line® Mini Mesh, designed for the repair of small umbilical and epigastric hernias. The device incorporates the company's patented T-Line® tension-distribution technology to improve fixation strength and reduce recurrence risk.
April 2026 Becton, Dickinson and Company (BD) received U.S. FDA 510(k) clearance and launched the Phasix™ ST Umbilical Hernia Patch, the first bioabsorbable hernia patch specifically indicated for umbilical hernia repair. The implant is manufactured from poly-4-hydroxybutyrate (P4HB) and is designed to provide temporary reinforcement while gradually resorbing after tissue healing.
December 2025 Lattice Medical received U.S. FDA 510(k) clearance for its Lattice Hernia Mesh intended for soft-tissue reinforcement in hernia repair procedures, expanding its surgical implant portfolio.
June 2025 Tela Bio, Inc. announced the full U.S. commercial launch of OviTex IHR Reinforced Tissue Matrix, expanding its reinforced biologic portfolio for inguinal hernia repair. The device combines biologic tissue with polymer reinforcement to support abdominal wall reconstruction and inguinal hernia procedures.